Skip to content
Screener

Pro-Dex, Inc. PDEX Free cash flow

Free cash flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$7.3B+157%
Stryker logo
StrykerSYK
$1.06B+14.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$393.6M+20.0%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$813K-50.7%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$18.87M

Other financials

Income statement

See full
Revenue$19.9M+14.6%
Gross profit$6.1M+5.8%
Operating income$3.1M-15.0%
Net income$3.9M+20.2%
EPS (diluted)$1.20+22.4%

Balance sheet

See full
Cash & equivalents$10.0M+123%
Total debt$16.0M+43.2%
Total equity$45.2M+28.1%
Total assets$75.0M+16.7%

Cash flow

See full
Operating cash flow$1.6M+488%
CapEx$112.0K-37.8%

Valuation

See full
Market cap$203.83M+37.4%
Enterprise value$209.81M+32.9%
P/E17×+0.5×
P/S2.7×+0.5×

Profitability

See full
Gross margin27.8%-3.6pp
Operating margin14.5%-3.8pp
Net margin16.1%+1.5pp
FCF margin-3.8%+3.2pp

Returns & leverage

See full
Return on equity29.8%+1.5pp
Debt / equity0.4×0.0×
Current ratio3.7×+0.9×

Where this comes from

Calculated from Pro-Dex, Inc.’s reported figures.

The source filing: Pro-Dex, Inc.’s 10-Q, filed April 30, 2026. Open the filing →

Filed
Apr 30, 2026, 4:00 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001079973-26-000580

FAQ

What is Pro-Dex, Inc.'s free cash flow?
Pro-Dex, Inc. (PDEX) reported free cash flow of $1.52M in Q1 2026.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Pro-Dex, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude